StemoniX: StemoniX's Merger with Cancer Genetics
Taft Stettinius & Hollister LLP advised StemoniX, Inc on the deal. Cancer Genetics, Inc. (the "Company" or "CGI") (Nasdaq: CGIX), an emerging leader in novel drug [...]
Read full article »
StemoniX is a biotechnology company that develops human iPSC-based screening products for pharmaceutical and research organizations.
Read more